Business Express is an online portal that covers the latest developments in the world of business and finance. From startups and entrepreneurship to mergers and acquisitions, Business Express provides reporting on the stories that matter most to business leaders and decision-makers.The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.
2021 08 06T105430Z 1 LYNXMPEH750M7 RTROPTP 4 HEALTH CORONAVIRUS BRITAIN - Business Express
FILE PHOTO: A person walks past Bank underground station during morning rush hour, amid the coronavirus disease (COVID-19) pandemic in London, Britain, July 29, 2021. REUTERS/Henry Nicholls

Early signs COVID-19 vaccines may not stop Delta transmission, England says


LONDON (Reuters) -There are early signs that people who have been vaccinated against COVID-19 may be able to transmit the Delta variant of the virus as easily as those who have not, scientists at Public Health England (PHE) said on Friday.

The findings chime with those from the U.S. Centers for Disease Control and Prevention, which last week raised concerns that vaccinated people infected with Delta could, unlike with other variants, readily transmit it.

The highly infectious Delta variant has become the dominant coronavirus type globally, sustaining a pandemic that has already killed more than 4.4 million people, including over 130,000 in Britain.

Vaccines have been shown to provide good protection against severe disease and death from Delta, especially with two doses, but there is less data on whether vaccinated people can still transmit it to others.

“Some initial findings … indicate that levels of virus in those who become infected with Delta having already been vaccinated may be similar to levels found in unvaccinated people,” PHE said in a statement.

“This may have implications for people’s infectiousness, whether they have been vaccinated or not. However, this is early exploratory analysis and further targeted studies are needed to confirm whether this is the case.”

PHE said that of confirmed Delta cases that had ended up hospitalised since July 19, 55.1% were unvaccinated, while 34.9% had received two doses of a COVID-19 vaccine.

Don't miss out on any breaking news or insightful opinions!
Subscribe to our free newsletter and stay updated on the go!


By submitting this form, you are consenting to receive marketing emails from: Global Banking & Finance Review. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email.

Nearly 75% of the British population has had two vaccine doses, and PHE said that “as more of the population gets vaccinated, we will see a higher relative percentage of vaccinated people in hospital”.

Separately, PHE said another variant, known as B.1.621, first detected in Colombia, had shown signs of evading the immune response triggered by either COVID-19 vaccines or previous infection.

PHE has labelled the variant “under investigation” but has not declared it a “variant of concern” – a designation that can trigger strong policy responses.

“There is preliminary laboratory evidence to suggest that vaccination and previous infection may be less effective at preventing infection with (B.1.621),” it said, adding there had been 37 confirmed cases of the variant in England.

“However, this data is very limited and more research is required. There is no evidence to suggest that (it) is more transmissible than the dominant Delta variant.”

(Reporting by Alistair SmoutEditing by Costas Pitas and Mark Potter)

 

Recent Post: